David Conley, MD
Otolaryngology · Chicago, ILNPI 1437112190
Payments from drug & device makers
Across 544 payments — averaging $1158.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$284K
- Intersect ENT, Inc.$124K
- Sanofi$121K
- Medtronic$98K
- Aerin Medical Inc.$873
- Stryker$705
- plus $955 from 6 others
What the payments were for
- Consulting fees$43,5967%
- Speaking & faculty fees$481,08876%
- Travel & lodging$84,89613%
- Food & beverage$20,7603%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 258 | $284,411 |
| Intersect ENT, Inc. | 92 | $123,632 |
| Sanofi | 62 | $121,370 |
| Medtronic(2 entities) | 109 | $98,393 |
| Aerin Medical Inc. | 7 | $873 |
| Stryker | 5 | $705 |
| Acclarent, Inc | 4 | $361 |
| GSK | 2 | $216 |
| Optinose US, Inc. | 1 | $133 |
| AstraZeneca | 2 | $126 |
| Xoran Technologies LLC | 1 | $81 |
| Johnson & Johnson | 1 | $37 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$334,502
- PROPEL$52,811
- SINUVA$15,309
- VIVAER STYLUS$726
- RHINAER STYLUS$726
- ENTELLUS - XPRESS ENT DILATION SYSTEM$548
- FUSION$455
- TruDi Nav Cable$317
- XPRESS ENT DILATION SYSTEM$157
- Chitogel$144
- Xhance$133
- NUVENT$129
- NUCALA$124
How this compares
$630,341 in reported general payments places this provider in the 95th percentile of 390 otolaryngology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 93 | $1,598 |
| Ipratropium Bromide | 66 | $1,501 |
| Mometasone Furoate | 12 | $792 |
| Fluticasone Propionate | 47 | $509 |
| Doxycycline Hyclate | 20 | $289 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Chicago
- Bruce TanChicago$940K
- Jayant PintoChicago$747K
- Robert KernChicago$610K
- Mihir BhayaniChicago$298K
- Samer Al-KhudariChicago$251K
- T K VenkatesanChicago$223K
- Bobby TajudeenChicago$214K
- Victoria LeeChicago$147K
- Sukhpreet BatraChicago$126K
- Phillip LosavioChicago$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.